Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

This study is testing software called "Lipidica 1.0" that analyzes fat molecule (lipid) patterns in blood to help detect or screen for pancreatic cancer. The study includes both patients who already have diagnosed pancreatic cancer and people at high genetic risk of developing it. The goal is to see if this tool can identify pancreatic cancer earlier than current methods. **You may be eligible if...** - You are 18 years of age or older - You have been diagnosed with surgically removable pancreatic cancer (Arm 1), OR - You are at high risk of pancreatic cancer due to a family history (2+ relatives with pancreatic cancer) or a confirmed genetic mutation such as BRCA2, CDKN2A, STK11, ATM, or others (Arm 2) **You may NOT be eligible if...** - You have had any other cancer - You have an incurable malignancy - You are not eligible for surgery (Arm 1) - You follow a vegan or vegetarian diet - You do not meet the genetic or family history criteria for high-risk screening (Arm 2) Talk to your doctor to see if this trial is right for you.